BioCentury
ARTICLE | Company News

CrystalGenomics, Daewoong Pharmaceutical deal

February 16, 2015 8:00 AM UTC

CrystalGenomics granted Daewoong exclusive rights to commercialize Acelex polmacoxib to treat osteoarthritis in Korea. CrystalGenomics will receive an upfront payment and is eligible for milestone p...